Coombe Gary A 4
4 · PROCTER & GAMBLE Co · Filed Dec 2, 2024
Insider Transaction Report
Form 4
Coombe Gary A
CEO - Grooming
Transactions
- Award
Restricted Stock Units
2024-11-15+46.163→ 900.635 total→ Common Stock (46.163 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-27−47,847→ 0 totalExercise: $91.07From: 2020-02-28Exp: 2027-02-26→ Common Stock (47,847 underlying) - Exercise/Conversion
Common Stock
2024-11-27$91.07/sh+47,847$4,357,426→ 87,824.172 total - Sale
Common Stock
2024-11-27$179.84/sh−47,847$8,604,685→ 39,977.172 total
Holdings
- 466.15(indirect: By Trust)
Common Stock
- 1,295.35(indirect: International Stock Ownership Plan & Pension Plan (Switzerland))
Common Stock
Footnotes (5)
- [F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan.
- [F2]Weighted average price of the shares sold. The price range was $179.60 to $180.04. Full information regarding the number of shares sold at each separate price available upon request.
- [F3]Reflects adjustment to PST through September 30, 2024.
- [F4]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
- [F5]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.